Genmab A/S

Stocks

Market Closed - Nasdaq Copenhagen 11:20:00 2026-08-13 EDT			5-day change	1st Jan Change
2,025.00 ^DKK	-0.59%		+7.88%	-0.10%

08-12	BNP Paribas Initiates Genmab at Outperform, With $40 Price Target	MT
08-12	Nordic stocks in North America: AstraZeneca fell 1.0%	FW

Published on 07/25/2025 at 07:37 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Hello, and welcome to Genmab's 2025 Post-ASCO Virtual R&D Update. As a reminder, this conference call is being recorded. During this telephone

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

08-12	BNP Paribas Initiates Genmab at Outperform, With $40 Price Target	MT
08-12	Nordic stocks in North America: AstraZeneca fell 1.0%	FW
08-11	Nordic stocks in North America, Ericsson fell 0.9%	FW
08-10	Nordic stocks in North America - Astra Zeneca rose 0.9 percent	FW
08-07	Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data	RE
08-07	Genmab: Q2 beat reinforces the investment story; diversification efforts remain on course
08-07	Genmab A/S, H1 2026 Earnings Call, Aug 06, 2026
08-07	UBS raises Genmab price target to 2,700 Danish kroner (2,600), reiterates buy	FW
08-07	Genmab soars after raising its guidance
08-07	U.S. Futures Mixed, European Stocks Up	DJ
08-07	Healthcare leads European shares higher; Middle East in focus	RE
08-07	Analysts upbeat on Genmab after strong Q2	FW
08-07	Goldman Sachs raises Genmab target price to 2,400 Danish kroner (2,350), reiterates buy - BN	FW
08-07	TD Cowen raises Genmab price target to 2,892 Danish kroner (2,851), reiterates buy	FW
08-07	Jyske Bank raises Genmab target price to 2 350 Danish kroner (2 300), reiterates buy - BN	FW